CVE-2009-1334

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in login/FilepathLogin.html in IBM Tivoli Continuous Data Protection (CDP) for Files 3.1.4.0 allows remote attackers to inject arbitrary web script or HTML via the reason parameter.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 5.90% Top 10%
Vendor Advisory secunia.com Vendor Advisory vupen.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://secunia.com/advisories/34646 third party advisory vendor advisory
http://www.osvdb.org/53651 vdb entry exploit
http://www.securityfocus.com/bid/34513 vdb entry exploit
http://www.insight-tech.org/index.php?p=IBM-Tivoli-Continuous-Data-Protection-for-Files-version-3-1-4-0---XSS url repurposed exploit
http://securitytracker.com/id?1022060 vdb entry exploit
https://exchange.xforce.ibmcloud.com/vulnerabilities/49872 vdb entry
http://www.vupen.com/english/advisories/2009/1021 vdb entry vendor advisory

Frequently Asked Questions

What is the severity of CVE-2009-1334?
CVE-2009-1334 has been scored as a medium severity vulnerability.
How to fix CVE-2009-1334?
To fix CVE-2009-1334, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2009-1334 being actively exploited in the wild?
It is possible that CVE-2009-1334 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~6% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.